Literature DB >> 25544409

Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.

Rubén Díez-Rodríguez, María Dolores Ballesteros-Pomar, Alicia Calleja-Fernández, Tomás González-De-Francisco, Luis González-Herráez, Sara Calleja-Antolín, Isidoro Cano-Rodríguez, José Luis Olcoz-Goñi.   

Abstract

The visceral adiposity index (VAI) is a marker of visceral fat distribution and dysfunction. Visceral adiposity is related to nonalcoholic fatty liver disease (NAFLD); however, there is some controversy regarding the association between VAI and NAFLD.The aim of this study was to analyse the relationship between VAI and NAFLD and to describe the related factors in severely obese patients. A total of 139 patients who underwent bariatric surgery were included in this cross-sectional study. Liver biopsy was performed during surgery. Univariate and multivariate analysis were conducted to study the features related to VAI. A univariate analysis was conducted to identify which factors were associated with liver histology. In the univariate analysis, steatosis, liver inflammation, non-alcoholic steatohepatitis (NASH) and fibrosis were associated with VAI. In the multivariate analysis, only HOMA (Beta: 0.06; p < 0.01) and metabolic syndrome (Beta: 1.23; p < 0.01) were related to VAI. HOMA, the presence of metabolic syndrome, and waist circumference (WC) were statistically related to the NAFLD activity score (NAS score): HOMA: 0-2: 5.04; 3-4: 7.83; > or = 5: 11,32; p < 0.01; MS: 0-2: 37 %; 3-4: 33.3 %; > or = 5: 76%; p < 0.01; WC: 0-2: 128.7 cm; 3-4: 130.7; > or = 5: 140.6; p < 0.01). For the prediction of NASH (NAS score > or = 5), the AUROC curve were 0.71 (CI 95 %: 0.63-0.79) for VAI and 0.7 (CI 95 %: 0.62-0.78) for WC. In conclusion, HOMA, WC and metabolic syndrome are related to liver histology in patients with severe obesity. In the multivariate analysis, VAI was associated with HOMA and metabolic syndrome, but not with liver histology.

Entities:  

Mesh:

Year:  2014        PMID: 25544409

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  8 in total

1.  Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.

Authors:  Iria Cebreiros López; Florentina Guzmán Aroca; Maria Dolores Frutos Bernal; Juan Antonio Luján Mompeán; Águeda Bas Bernal; Antonio Miguel Hernández Martínez; Enrique Martínez Barba; Jose Antonio Noguera Velasco; Pascual Parilla Paricio
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

2.  Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome.

Authors:  Silan Zheng; Meifeng Tong; Lianqin Dong; Chunmin Du; Xin Zheng; Liying Wang; Peiying Huang; Wei Liu; Mingzhu Lin; Changqin Liu
Journal:  Endocr Connect       Date:  2020-02       Impact factor: 3.335

3.  Determination of "indeterminate score" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia.

Authors:  Yasir Mohammed Khayyat
Journal:  World J Hepatol       Date:  2021-12-27

4.  Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.

Authors:  Jinwei Cai; Cuiting Lin; Shuiqing Lai; Yingshan Liu; Min Liang; Yingfen Qin; Xinghuan Liang; Aihua Tan; Yong Gao; Zheng Lu; Chunlei Wu; Shengzhu Huang; Xiaobo Yang; Haiying Zhang; Jian Kuang; Zengnan Mo
Journal:  Lipids Health Dis       Date:  2021-10-27       Impact factor: 3.876

5.  Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study.

Authors:  Qianwen Li; Ling Wang; Jian Wu; Jing Wang; Yanjie Wang; Xin Zeng
Journal:  BMJ Open       Date:  2022-03-21       Impact factor: 2.692

Review 6.  The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Moniba Bijari; Sara Jangjoo; Nima Emami; Sara Raji; Mahdi Mottaghi; Roya Moallem; Ali Jangjoo; Amin Saberi
Journal:  Int J Endocrinol       Date:  2021-07-26       Impact factor: 3.257

7.  Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Authors:  Atsuko Nakatsuka; Makoto Matsuyama; Satoshi Yamaguchi; Akihiro Katayama; Jun Eguchi; Kazutoshi Murakami; Sanae Teshigawara; Daisuke Ogawa; Nozomu Wada; Tetsuya Yasunaka; Fusao Ikeda; Akinobu Takaki; Eijiro Watanabe; Jun Wada
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

Review 8.  The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.

Authors:  Abdulrahman Ismaiel; Ayman Jaaouani; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Dan L Dumitrascu
Journal:  Biomedicines       Date:  2021-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.